RNA m⁶A modification regulates cell fate transition between pluripotent stem cells and 2-cell-like cells

Abstract

N⁶-methyladenosine (m⁶A) exerts essential roles in early embryos, especially in the maternal-to-zygotic transition stage. However, the landscape and roles of RNA m⁶A modification during the transition between pluripotent stem cells and 2-cell-like (2C-like) cells remain elusive. Here, we utilised ultralow-input RNA m⁶A immunoprecipitation to depict the dynamic picture of transcriptome-wide m⁶A modifications during 2C-like transitions. We found that RNA m⁶A modification was preferentially enriched in zygotic genome activation (ZGA) transcripts and MERVL with high expression levels in 2C-like cells. During the exit of the 2C-like state, m⁶A facilitated the silencing of ZGA genes and MERVL. Notably, inhibition of m⁶A methyltransferase METTL3 and m⁶A reader protein IGF2BP2 is capable of significantly delaying 2C-like state exit and expanding 2C-like cells population. Together, our study reveals the critical roles of RNA m⁶A modification in the transition between 2C-like and pluripotent states, facilitating the study of totipotency and cell fate decision in the future.

References

[1] XuQ, XieW. Epigenome in early mammalian development: inheritance, reprogramming and establishment. Trends Cell Biol. 2018; 28(3):237-253.

[2] BouniolC, NguyenE, DebeyP. Endogenous transcription occurs at the 1-cell stage in the mouse embryo. Exp Cell Res. 1995; 218(1):57-62.

[3] LuF, ZhangY. Cell totipotency: molecular features, induction, and maintenance. Natl Sci Rev. 2015; 2(2):217-225.

[4] SchultzRM. Regulation of zygotic gene activation in the mouse. Bioessays. 1993; 15(8):531-538.

[5] TarkowskiAK. Experiments on the development of isolated blastomeres of mouse eggs. Nature. 1959; 184(4695):1286-1287.

[6] TarkowskiAK, Wróblewska J. Development of blastomeres of mouse eggs isolated at the 4- and 8-cell stage. J Embryol Exp Morphol. 1967; 18(1):155-180.

[7] FalcoG, LeeSL, StanghelliniI, BasseyUC, Hamatani T, KoMS. Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. Dev Biol. 2007; 307(2):539-550.

[8] GabriëlsJ, Beckers MC, DingH, et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene. 1999; 236(1):25-32.

[9] GengLN, YaoZ, SniderL, et al. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell. 2012; 22(1):38-51.

[10] GuoM, ZhangY, ZhouJ, et al. Precise temporal regulation of Dux is important for embryo development. Cell Res. 2019; 29(11):956-959.

[11] CokerH, WeiG, BrockdorffN. m⁶A modification of non-coding RNA and the control of mammalian gene expression. Biochim Biophys Acta Gene Regul Mech. 2019; 1862(3):310-318.

[12] LiuJ, DouX, ChenC, et al. N⁶-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science. 2020; 367(6477):580-586.

[13] LiuJ, GaoM, HeJ, et al. The RNA m⁶A reader YTHDC1 silences retrotransposons and guards ES cell identity. Nature. 2021; 591(7849):322-326.

[14] RoundtreeIA, EvansME, PanT, HeC. Dynamic RNA modifications in gene expression regulation. Cell. 2017; 169(7):1187-1200.

[15] YueY, LiuJ, HeC. RNA N⁶-methyladenosine methylation in post-transcriptional gene expression regulation. Genes Dev. 2015; 29(13):1343-1355.

[16] WangY, LiY, SkulandT, et al. The RNA m⁶A landscape of mouse oocytes and preimplantation embryos. Nat Struct Mol Biol. 2023; 30(5):703-709.

[17] IvanovaI, MuchC, Di GiacomoM, et al. The RNA m⁶A reader YTHDF2 is essential for the post-transcriptional regulation of the maternal transcriptome and oocyte competence. Mol Cell. 2017; 67(6):1059-1067.e4.

[18] LiuHB, Muhammad T, GuoY, et al. RNA-binding protein IGF2BP2/IMP2 is a critical maternal activator in early zygotic genome activation. Adv Sci. 2019; 6(15):1900295.

[19] WuY, XuX, QiM, et al. N⁶-methyladenosine regulates maternal RNA maintenance in oocytes and timely RNA decay during mouse maternal-to-zygotic transition. Nat Cell Biol. 2022; 24(6):917-927.

[20] MacfarlanTS, Gifford WD, DriscollS, et al. Embryonic stem cell potency fluctuates with endogenous retrovirus activity. Nature. 2012; 487(7405):57-63.

[21] ZalzmanM, FalcoG, SharovaLV, et al. Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature. 2010; 464(7290):858-863.

[22] ChenZ, ZhangY. Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development. Nat Genet. 2019; 51(6):947-951.

[23] De IacoA, Coudray A, DucJ, TronoD. DPPA2 and DPPA4 are necessary to establish a 2C-like state in mouse embryonic stem cells. EMBO Rep. 2019; 20(5):e47382.

[24] De IacoA, PlanetE, ColuccioA, Verp S, DucJ, TronoD. DUX-family transcription factors regulate zygotic genome activation in placental mammals. Nat Genet. 2017; 49(6):941-945.

[25] Eckersley-MaslinM, Alda-Catalinas C, BlotenburgM, KreibichE, Krueger C, ReikW. Dppa2 and Dppa4 directly regulate the dux-driven zygotic transcriptional program. Genes Dev. 2019; 33(3–4):194-208.

[26] HendricksonPG, Doráis JA, GrowEJ, et al. Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons. Nat Genet. 2017; 49(6):925-934.

[27] PerchardeM, LinCJ, YinY, et al. A LINE1-Nucleolin partnership regulates early development and ESC identity. Cell. 2018; 174(2):391-405.e319.

[28] TianQ, WangXF, XieSM, Yin Y, ZhouLQ. H3.3 impedes zygotic transcriptional program activated by dux. Biochem Biophys Res Commun. 2020; 522(2):422-427.

[29] WhiddonJL, Langford AT, WongCJ, ZhongJW, Tapscott SJ. Conservation and innovation in the DUX4-family gene network. Nat Genet. 2017; 49(6):935-940.

[30] YanYL, ZhangC, HaoJ, et al. DPPA2/4 and SUMO E3 ligase PIAS4 opposingly regulate zygotic transcriptional program. PLoS Biol. 2019; 17(6):e3000324.

[31] ZhangW, ChenF, ChenR, et al. Zscan4c activates endogenous retrovirus MERVL and cleavage embryo genes. Nucleic Acids Res. 2019; 47(16):8485-8501.

[32] XuY, ZhaoJ, RenY, et al. Derivation of totipotent-like stem cells with blastocyst-like structure forming potential. Cell Res. 2022; 32(6):513-529.

[33] YangM, YuH, YuX, et al. Chemical-induced chromatin remodeling reprograms mouse ESCs to totipotent-like stem cells. Cell Stem Cell. 2022; 29(3):400-418.e13.

[34] ChenC, LiuW, GuoJ, et al. Nuclear m⁶A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos. Protein Cell. 2021; 12(6):455-474.

[35] ZhangY, HuangY, DongY, et al. Unique patterns of H3K4me3 and H3K27me3 in 2-cell-like embryonic stem cells. Stem Cell Rep. 2021; 16(3):458-469.

[36] LiH, SunJ, DongY, et al. Remodeling of H3K9me3 during the pluripotent to totipotent-like state transition. Stem Cell Rep. 2023; 18(2):449-462.

[37] Eckersley-MaslinMA, Svensson V, KruegerC, et al. MERVL/Zscan4 network activation results in transient genome-wide DNA demethylation of mESCs. Cell Rep. 2016; 17(1):179-192.

[38] DominissiniD, Moshitch-Moshkovitz S, SchwartzS, et al. Topology of the human and mouse m⁶A RNA methylomes revealed by m⁶A-seq. Nature. 2012; 485(7397):201-206.

[39] XiaoS, CaoS, HuangQ, et al. The RNA N⁶-methyladenosine modification landscape of human fetal tissues. Nat Cell Biol. 2019; 21(5):651-661.

[40] Eckersley-MaslinMA, Alda-Catalinas C, ReikW. Dynamics of the epigenetic landscape during the maternal-to-zygotic transition. Nat Rev Mol Cell Biol. 2018; 19(7):436-450.

[41] GiffordWD, PfaffSL, MacfarlanTS. Transposable elements as genetic regulatory substrates in early development. Trends Cell Biol. 2013; 23(5):218-226.

[42] PeastonAE, Evsikov AV, GraberJH, et al. Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos. Dev Cell. 2004; 7(4):597-606.

[43] FuX, Djekidel MN, ZhangY. A transcriptional roadmap for 2C-like-to-pluripotent state transition. Sci Adv. 2020; 6(22):eaay5181.

[44] HuangH, WengH, SunW, et al. Recognition of RNA N⁶-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018; 20(3):285-295.

[45] YankovaE, Blackaby W, AlbertellaM, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021; 593(7860):597-601.

[46] LiuJ, YueY, HanD, et al. A METTL3–METTL14 complex mediates mammalian nuclear RNA N⁶-adenosine methylation. Nat Chem Biol. 2014; 10(2):93-95.

[47] YangF, HuangX, ZangR, et al. DUX-miR-344-ZMYM2-mediated activation of MERVL LTRs induces a totipotent 2C-like state. Cell Stem Cell. 2020; 26(2):234-250.e7.

[48] WengH, HuangF, YuZ, et al. The m⁶A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022; 40(12):1566-1582.e10.

[49] ZhaoBS, WangX, BeadellAV, et al. m⁶A-dependent maternal mRNA clearance facilitates zebrafish maternal-to-zygotic transition. Nature. 2017; 542(7642):475-478.

[50] BatistaPJ, Molinie B, WangJ, et al. m⁶A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014; 15(6):707-719.

[51] YuG, WangLG, HanY, HeQY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012; 16(5):284-287.

[52] HaoY, HaoS, Andersen-NissenE, et al. Integrated analysis of multimodal single-cell data. Cell. 2021; 184(13):3573-3587.e29.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.